FEG
ACHC icon

Fund Evaluation Group’s Acadia Healthcare ACHC Stock Holding History

Fund Evaluation Group’s Portfolio ACHC Stock Details ACHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-26,376
Closed -$928K – 23
2018
Q3 		$928K Sell
26,376
-1,774
-6% -$70.7K 0.15% 76
2018
Q2 		$1.15M Hold
28,150
– – 0.18% 66
2018
Q1 		$1.1M Hold
28,150
– – 0.12% 65
2017
Q4 		$919K Buy
+28,150
New +$975K 0.1% 77

Other funds holding ACHC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fund Evaluation Group's ACHC Position: Q4 2018 in Review

Fund Evaluation Group sold out of Acadia Healthcare (ACHC) in Q4 2018, closing a stake of 26,376 shares — an estimated $928K sold.

Fund Evaluation Group first reported a position in ACHC in Q4 2017 and held it in 4 quarters. The position peaked at $1.15M in Q2 2018. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2018.

  • Fund Evaluation Group reported no remaining Acadia Healthcare position as of Q4 2018 after selling out during the quarter.
  • Fund Evaluation Group sold 26,376 Acadia Healthcare shares in Q4 2018, an estimated $928K.
  • Fund Evaluation Group first reported a position in Acadia Healthcare in Q4 2017 and held it in 4 quarters.
  • Fund Evaluation Group's Acadia Healthcare position peaked at $1.15M in Q2 2018.
  • 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2018.

Based on Fund Evaluation Group's 13F filing for Q4 2018, filed 12 Feb 2019.